%0 Review
%T Molecular glues targeting GSPT1 in cancers: A potent therapy.
%A Zhang D
%A Lin P
%A Lin J
%J Bioorg Chem
%V 143
%N 0
%D 2024 Feb 25
%M 38029571
%F 5.307
%R 10.1016/j.bioorg.2023.107000
%X G1 to S phase transition 1 (GSPT1) is a key translation termination factor that significantly overexpressed in various cancer tissues and cells. Molecular glue is a kind of small molecule, which can bind to an E3 ligase such as cereblon (CRBN) and subsequently recruit neosubstrate proteins for ubiquitination-proteasomal degradation. This emerging therapeutic approach shows great potential in treating cancers and other diseases. This review aims to introduce current understanding of antitumor mechanism of molecular glues targeting GSPT1, summarize pharmacology profiles of existing molecular glues, and outline development strategies of novel molecular glues. The insights provided in this review will be valuable for future studies.